New Hyperuricemia Findings from Tianjin Medical University Outlined (Edible Mushroom Consumption and Incident Hyperuricemia: Results From the Tclsih Cohort Study)

摘要

2021 SEP 21 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Current study results on Hyperuricemia have been published. According to news originating from Tianjin, People's Republic of China, by NewsRx correspondents, research stated, "Basic studies have found that xanthine oxidase inhibitors extracted from mushrooms have inhibitory effects on hyperuricemia. However, the association between mushroom consumption and hyperuricemia is unknown in humans." Financial support for this research came from National Natural Science Foundation of China (NSFC). Our news journalists obtained a quote from the research from Tianjin Medical University, "We therefore designed a large-scale cohort study to examine whether mushroom consumption is a protective factor for developing hyperuricemia in adults. This prospective cohort study investigated 19 830 participants (mean age: 39.4 years; and 9906 [50.0%] men) who were free of hyperuricemia, cardiovascular disease, and cancer at the baseline. Mushroom consumption was measured at the baseline using a validated food frequency questionnaire. Hyperuricemia is defined as serum uric acid levels >420 mu mol L-l in men and >350 mu mol L-l in women. Cox proportional hazards regression models were used to examine the association of mushroom consumption with incident hyperuricemia. Restricted cubic spline regression was used to estimate the dose-response relationship between mushroom consumption and risk of hyperuricemia.